Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Influenza

  Free Subscription


Articles published in Arch Virol

Retrieve available abstracts of 85 articles:
HTML format
Text format



Single Articles


    March 2017
  1. JAGADESH A, Salam AA, Zadeh VR, Krishnan A, et al
    Molecular characterization of neuraminidase genes of influenza A(H3N2) viruses circulating in Southwest India from 2009 to 2013.
    Arch Virol. 2017 Mar 7. doi: 10.1007/s00705-017-3306.
    PubMed     Text format     Abstract available


    February 2017
  2. LIAO SH, Li Y, Lai YN, Liu N, et al
    Ribavirin attenuates the respiratory immune responses to influenza viral infection in mice.
    Arch Virol. 2017 Feb 27. doi: 10.1007/s00705-017-3291.
    PubMed     Text format     Abstract available


  3. SAAVEDRA-MONTANEZ M, Castillo-Juarez H, Sanchez-Betancourt I, Rivera-Benitez JF, et al
    Serological study of influenza viruses in veterinarians working with swine in Mexico.
    Arch Virol. 2017 Feb 23. doi: 10.1007/s00705-017-3282.
    PubMed     Text format     Abstract available


    January 2017
  4. ZHAI JQ, Zhai SL, Lin T, Liu JK, et al
    First complete genome sequence of parainfluenza virus 5 isolated from lesser panda.
    Arch Virol. 2017 Jan 30. doi: 10.1007/s00705-017-3245.
    PubMed     Text format     Abstract available


  5. MARCHENKO VY, Susloparov IM, Komissarov AB, Fadeev A, et al
    Reintroduction of highly pathogenic avian influenza A/H5N8 virus of clade 2.3.4.4. in Russia.
    Arch Virol. 2017 Jan 30. doi: 10.1007/s00705-017-3246.
    PubMed     Text format     Abstract available


  6. FOTOUHI F, Shaffifar M, Farahmand B, Shirian S, et al
    Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
    Arch Virol. 2017 Jan 24. doi: 10.1007/s00705-017-3230.
    PubMed     Text format     Abstract available


  7. JIA Y, Yang J, Wang Z, Du Y, et al
    Genetic properties and pathogenicity of a novel reassortant H10N5 influenza virus from wild birds.
    Arch Virol. 2017 Jan 23. doi: 10.1007/s00705-017-3234.
    PubMed     Text format     Abstract available


  8. YANG CH, Li HC, Shiu YL, Ku TS, et al
    Influenza A virus upregulates PRPF8 gene expression to increase virus production.
    Arch Virol. 2017 Jan 21. doi: 10.1007/s00705-016-3210.
    PubMed     Text format     Abstract available


  9. WU H, Lu R, Peng X, Peng X, et al
    Molecular characterization of a novel reassortant H7N6 subtype avian influenza virus from poultry in Eastern China, in 2016.
    Arch Virol. 2017 Jan 19. doi: 10.1007/s00705-017-3219.
    PubMed     Text format     Abstract available


  10. LEE IH, Kim HS, Seo SH
    Porcine mast cells infected with H1N1 influenza virus release histamine and inflammatory cytokines and chemokines.
    Arch Virol. 2017 Jan 2. doi: 10.1007/s00705-016-3216.
    PubMed     Text format     Abstract available


    December 2016
  11. YAN Y, Gu JY, Yuan ZC, Chen XY, et al
    Genetic characterization of H9N2 avian influenza virus in plateau pikas in the Qinghai Lake region of China.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  12. BHOWMICK S, Chakravarty C, Sellathamby S, Lal SK, et al
    The influenza A virus matrix protein 2 undergoes retrograde transport from the endoplasmic reticulum into the cytoplasm and bypasses cytoplasmic proteasomal degradation.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  13. BASHIR U, Nisar N, Arshad Y, Alam MM, et al
    Respiratory syncytial virus and influenza are the key viral pathogens in children <2 years hospitalized with bronchiolitis and pneumonia in Islamabad Pakistan.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  14. SHITTU I, Meseko CA, Gado DA, Olawuyi AK, et al
    Highly pathogenic avian influenza (H5N1) in Nigeria in 2015: evidence of widespread circulation of WA2 clade 2.3.2.1c.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  15. EL-SHESHENY R, Mostafa A, Kandeil A, Mahmoud SH, et al
    Biological characterization of highly pathogenic avian influenza H5N1 viruses that infected humans in Egypt in 2014-2015.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  16. QU X, Ding X, Duan M, Yang J, et al
    Influenza virus infection induces translocation of apoptosis-inducing factor (AIF) in A549 cells: role of AIF in apoptosis and viral propagation.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  17. BHAT S, Nagarajan S, Kumar M, Murugkar HV, et al
    Antigenic characterization of H5N1 highly pathogenic avian influenza viruses isolated from poultry in India, 2006-2015.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  18. INDALAO IL, Sawabuchi T, Takahashi E, Kido H, et al
    IL-1beta is a key cytokine that induces trypsin upregulation in the influenza virus-cytokine-trypsin cycle.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  19. SUN Y, Yang C, Li J, Li L, et al
    Construction of a recombinant duck enteritis virus vaccine expressing hemagglutinin of H9N2 avian influenza virus and evaluation of its efficacy in ducks.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  20. KYDYRMANOV A, Sayatov M, Karamendin K, Zhumatov K, et al
    Monitoring of influenza A viruses in wild bird populations in Kazakhstan in 2002-2009.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  21. UCHIDA Y, Kanehira K, Takemae N, Hikono H, et al
    Susceptibility of chickens, quail, and pigeons to an H7N9 human influenza virus and subsequent egg-passaged strains.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  22. KAEWBORISUTH C, Kaplan B, Zanin M, Finkelstein D, et al
    G45R on nonstructural protein 1 of influenza A virus contributes to virulence by increasing the expression of proinflammatory cytokines in mice.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  23. WANG X, Meng F, Wang D, Liu X, et al
    Characteristics of two highly pathogenic avian influenza H5N8 viruses with different pathogenicity in mice.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  24. RUDNEVA IA, Timofeeva TA, Ignatieva AV, Shilov AA, et al
    Effects of hemagglutinin amino acid substitutions in H9 influenza A virus escape mutants.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  25. SULTAN S, Bui VN, Hill NJ, Hussein IT, et al
    Genetic characterization of H5N2 influenza viruses isolated from wild birds in Japan suggests multiple reassortment.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  26. ZHANG W, Huang Q, Lu M, Zhu F, et al
    Exploration of the BF2*15 major histocompatibility complex class I binding motif and identification of cytotoxic T lymphocyte epitopes from the H5N1 influenza virus nucleoprotein in chickens.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  27. YANG Q, Mao Q, Liu M, Wang K, et al
    The inhibitory effect of dehydroepiandrosterone and its derivatives against influenza A virus in vitro and in vivo.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  28. LIU T, Li Z, Lin Y, Song S, et al
    Dynamic patterns of circulating influenza virus from 2005 to 2012 in Shandong Province, China.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  29. SAMY A, El-Enbaawy MI, El-Sanousi AA, Nasef SA, et al
    Initiation and regulation of immune responses to immunization with whole inactivated vaccines prepared from two genetically and antigenically distinct lineages of Egyptian influenza A virus subtype H5N1.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  30. QUINTILIO W, de Freitas FA, Rodriguez D, Kubrusly FS, et al
    Vitamins as influenza vaccine adjuvant components.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  31. SI YJ, Choi WS, Kim YI, Lee IW, et al
    Genetic characteristics of highly pathogenic H5N8 avian influenza viruses isolated from migratory wild birds in South Korea during 2014-2015.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  32. JIANG L, Changsom D, Lerdsamran H, Wiriyarat W, et al
    Immunobiological properties of influenza A (H7N9) hemagglutinin and neuraminidase proteins.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  33. LEE J, Park JH, Min JY
    A naturally truncated NS1 protein of influenza A virus impairs its interferon-antagonizing activity and thereby confers attenuation in vitro.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  34. CHAIYAWONG S, Boonyapisitsopa S, Jairak W, Nonthabenjawan N, et al
    Genetic characterization of influenza A virus subtypes H1N3 and H1N9 isolated from free-grazing ducks in Thailand.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  35. RAMEY AM, Kim Torchetti M, Poulson RL, Carter D, et al
    Evidence for wild waterfowl origin of H7N3 influenza A virus detected in captive-reared New Jersey pheasants.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  36. VARDAKAS KZ, Theocharis G, Tansarli GS, Rafailidis P, et al
    Impact of oseltamivir use on the reduction of complications in patients with influenza: a prospective study.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  37. GUAN L, Zhao LQ, Zhou HY, Nie K, et al
    Reverse transcription genome exponential amplification reaction assay for rapid and universal detection of human rhinoviruses.
    Arch Virol. 2016;161:1891-8.
    PubMed     Text format     Abstract available


    June 2016
  38. HUZLY D, Korn K, Bierbaum S, Eberle B, et al
    Influenza A virus drift variants reduced the detection sensitivity of a commercial multiplex nucleic acid amplification assay in the season 2014/15.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  39. JAGADESH A, Salam AA, Mudgal PP, Arunkumar G, et al
    Influenza virus neuraminidase (NA): a target for antivirals and vaccines.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  40. OKAMATSU M, Motohashi Y, Hiono T, Tamura T, et al
    Is the optimal pH for membrane fusion in host cells by avian influenza viruses related to host range and pathogenicity?
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  41. FANG S, Wang X, Dong F, Jin T, et al
    Genomic characterization of influenza A (H7N9) viruses isolated in Shenzhen, Southern China, during the second epidemic wave.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  42. LYOO KS, Na W, Yeom M, Jeong DG, et al
    Virulence of a novel reassortant canine H3N2 influenza virus in ferret, dog and mouse models.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  43. WU H, Lu R, Peng X, Peng X, et al
    Isolation and genetic characterization of novel reassortant H6N6 subtype avian influenza viruses isolated from chickens in eastern China.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  44. NAGUIB MM, Abdelwhab EM, Harder TC
    Evolutionary features of influenza A/H5N1 virus populations in Egypt: poultry and human health implications.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  45. RIDENOUR C, Williams SM, Jones L, Tompkins SM, et al
    Erratum to: Serial passage in ducks of a low-pathogenic avian influenza virus isolated from a chicken reveals a high mutation rate in the hemagglutinin that is likely due to selection in the host.
    Arch Virol. 2016.
    PubMed     Text format    


    March 2016
  46. PENG X, Wu H, Peng X, Wu X, et al
    Amino acid substitutions occurring during adaptation of an emergent H5N6 avian influenza virus to mammals.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  47. MOSTAFA A, Abdelwhab EM, Slanina H, Hussein MA, et al
    Phylogenetic analysis of human influenza A/H3N2 viruses isolated in 2015 in Germany indicates significant genetic divergence from vaccine strains.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  48. GE F, Li X, Ju H, Yang D, et al
    Genotypic evolution and antigenicity of H9N2 influenza viruses in Shanghai, China.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  49. MARCHENKO VY, Susloparov IM, Kolosova NP, Goncharova NI, et al
    Highly pathogenic influenza H5N1 virus of clade 2.3.2.1c in Western Siberia.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    February 2016
  50. TEWAWONG N, Chansaenroj J, Klinfueng S, Vichiwattana P, et al
    Lineage-specific detection of influenza B virus using real-time polymerase chain reaction with melting curve analysis.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  51. SHA J, Chen X, Ren Y, Chen H, et al
    Differences in the epidemiology and virology of mild, severe and fatal human infections with avian influenza A (H7N9) virus.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  52. JAIRAK W, Boonyapisitsopa S, Chaiyawong S, Nonthabenjawan N, et al
    Genetic characterization of influenza A (H7N6) virus isolated from a live-bird market in Thailand.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  53. WEI YR, Yang XY, Li YG, Wei J, et al
    Serological survey of avian influenza virus infection in non-avian wildlife in Xinjiang, China.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  54. CHEN D, Wen X, Sun Y, Mao H, et al
    Multiple viral introductions: molecular characterization of influenza B virus in Wenzhou, Zhejiang, China, from 2011 to 2014 based on hemagglutinin and neuraminidase genes.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    December 2015
  55. WU H, Peng X, Peng X, Cheng L, et al
    Multiple amino acid substitutions involved in the adaptation of avian-origin influenza A (H10N7) virus in mice.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  56. SHRINER SA, Root JJ, Mooers NL, Ellis JW, et al
    Susceptibility of rock doves to low-pathogenic avian influenza A viruses.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  57. LIMSUWAT N, Suptawiwat O, Boonarkart C, Puthavathana P, et al
    Sialic acid content in human saliva and anti-influenza activity against human and avian influenza viruses.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  58. MUZYKA D, Pantin-Jackwood M, Starick E, Fereidouni S, et al
    Evidence for genetic variation of Eurasian avian influenza viruses of subtype H15: the first report of an H15N7 virus.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  59. ZHANG S, Tian H, Cui J, Xiao J, et al
    The c-Jun N-terminal kinase (JNK) is involved in H5N1 influenza A virus RNA and protein synthesis.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  60. HIONO T, Okamatsu M, Igarashi M, McBride R, et al
    Amino acid residues at positions 222 and 227 of the hemagglutinin together with the neuraminidase determine binding of H5 avian influenza viruses to sialyl Lewis X.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  61. LI J, Gu M, Liu D, Liu B, et al
    Phylogenetic and biological characterization of three K1203 (H5N8)-like avian influenza A virus reassortants in China in 2014.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


    October 2015
  62. LI TW, Cheng SF, Tseng YT, Yang YC, et al
    Development of single-chain variable fragments (scFv) against influenza virus targeting hemagglutinin subunit 2 (HA2).
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


    September 2015
  63. OKUYA K, Kawabata T, Nagano K, Tsukiyama-Kohara K, et al
    Isolation and characterization of influenza A viruses from environmental water at an overwintering site of migratory birds in Japan.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  64. LEI H, Peng X, Zhao D, Jiao H, et al
    Cross-protection of Lactococcus lactis-displayed HA2 subunit against homologous and heterologous influenza A viruses in mice.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


    August 2015
  65. MARCHENKO VY, Susloparov IM, Kolosova NP, Goncharova NI, et al
    Influenza A(H5N8) virus isolation in Russia, 2014.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  66. KITTEL C, Wressnigg N, Shurygina AP, Wolschek M, et al
    A genetically adjuvanted influenza B virus vector increases immunogenicity and protective efficacy in mice.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  67. WU H, Peng X, Peng X, Wu N, et al
    Molecular characterization of a reassortant H11N9 subtype avian influenza virus isolated from a domestic duck in Eastern China.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  68. BAO H, Ma Y, Shi J, Zeng X, et al
    Evaluation and application of a one-step duplex real-time reverse transcription polymerase chain reaction assay for the rapid detection of influenza A (H7N9) virus from poultry samples.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  69. RIDENOUR C, Williams SM, Jones L, Tompkins SM, et al
    Serial passage in ducks of a low-pathogenic avian influenza virus isolated from a chicken reveals a high mutation rate in the hemagglutinin that is likely due to selection in the host.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  70. THAMMAKARN C, Tsujimura M, Satoh K, Hasegawa T, et al
    Efficacy of scallop shell powders and slaked lime for inactivating avian influenza virus under harsh conditions.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  71. KWIT K, Pomorska-Mol M, Markowska-Daniel I
    Pregnancy outcome and clinical status of gilts following experimental infection by H1N2, H3N2 and H1N1pdm09 influenza A viruses during the last month of gestation.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


    June 2015
  72. FUJIMOTO Y, Ito H, Tomita M, Ono E, et al
    Amino acid substitution at position 44 of matrix protein 2 of an avirulent H5 avian influenza virus is crucial for acquiring the highly pathogenic phenotype in chickens.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


    May 2015
  73. TRIPATHI S, Batra J, Lal SK
    Interplay between influenza A virus and host factors: targets for antiviral intervention.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  74. CHOI EH, Song MS, Park SJ, Pascua PN, et al
    Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


    April 2015
  75. KANEHIRA K, Uchida Y, Takemae N, Hikono H, et al
    Characterization of an H5N8 influenza A virus isolated from chickens during an outbreak of severe avian influenza in Japan in April 2014.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


    March 2015
  76. PARK WJ, Park BJ, Song YJ, Lee DH, et al
    Analysis of cytokine production in a newly developed canine tracheal epithelial cell line infected with H3N2 canine influenza virus.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  77. SANG X, Wang A, Chai T, He X, et al
    Rapid emergence of a PB2-E627K substitution confers a virulent phenotype to an H9N2 avian influenza virus during adaption in mice.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  78. WO Y, Lu QB, Huang DD, Li XK, et al
    Epidemical features of HAdV-3 and HAdV-7 in pediatric pneumonia in Chongqing, China.
    Arch Virol. 2015;160:633-8.
    PubMed     Text format     Abstract available


    February 2015
  79. FANG Q, Gao Y, Chen M, Guo X, et al
    Molecular epidemiology and evolution of influenza A and B viruses during winter 2013-2014 in Beijing, China.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  80. HUANG L, Ma J, Sun Y, Lv Y, et al
    Altered splenic miRNA expression profile in H1N1 swine influenza.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


    January 2015
  81. ZHU Y, Yang Y, Liu W, Liu X, et al
    Comparison of biological characteristics of H9N2 avian influenza viruses isolated from different hosts.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  82. TO KK, Zhang AJ, Chan AS, Li C, et al
    Recombinant influenza A virus hemagglutinin HA2 subunit protects mice against influenza A(H7N9) virus infection.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


    December 2014
  83. SUPTAWIWAT O, Boonarkart C, Chakritbudsabong W, Uiprasertkul M, et al
    The N-linked glycosylation site at position 158 on the head of hemagglutinin and the virulence of H5N1 avian influenza virus in mice.
    Arch Virol. 2014.
    PubMed     Text format     Abstract available


    November 2014
  84. KIM HM, Park EH, Yum J, Kim HS, et al
    Greater virulence of highly pathogenic H5N1 influenza virus in cats than in dogs.
    Arch Virol. 2014.
    PubMed     Text format     Abstract available


  85. HIYOSHI M, Indalao IL, Yano M, Yamane K, et al
    Influenza A virus infection of vascular endothelial cells induces GSK-3beta-mediated beta-catenin degradation in adherens junctions, with a resultant increase in membrane permeability.
    Arch Virol. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: